Q1 2022 Evofem Biosciences Inc Earnings Call Transcript
Greetings, and welcome to the Evofem Biosciences First Quarter of 2022 Financial Results Call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Amy Raskopf, Evofem's Vice President of Investor Relations. You may begin.
Thank you. Good afternoon, everyone, and welcome to the Evofem Biosciences Q1 2022 Results Call. If you haven't done so already, I encourage you to access the presentation that accompanies this call and the press release we issued at market close. Both of which may be found at evofem.com under the Investors tab.
Before we begin, I would like to remind you that remarks on this call will contain forward-looking statements, which are made only as of today, May 4, 2022. For a more detailed description of important risk factors that could cause our actual results to differ materially, please refer to our annual report on Form 10-K and our most recently filed 10-Q.
With that, I will turn the call over to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |